Chinese VCs Green Pine, Lilly Asia back Singlera's $60m Series A

Chinese investment firms Green Pine Capital Partners and Lilly Asia Ventures have backed the $60-million Series A funding round of US- and Shanghai-based non-invasive genetic diagnostic firm Singlera Genomics.